Ignite Creation Date:
2025-12-24 @ 7:49 PM
Ignite Modification Date:
2025-12-25 @ 5:25 PM
Study NCT ID:
NCT05698303
Status:
NOT_YET_RECRUITING
Last Update Posted:
2023-01-26
First Post:
2022-12-29
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
A Study of Fully Human BCMA Chimeric Antigen Receptor Autologous T Cell Injection (CT103A) in the Treatment of Patients With Relapsed/Refractory Multiple Myeloma
Sponsor:
Nanjing IASO Biotechnology Co., Ltd.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-05-08
Start Date Type:
ESTIMATED
Primary Completion Date:
2024-05-20
Primary Completion Date Type:
ESTIMATED
Completion Date:
2026-01-15
Completion Date Type:
ESTIMATED
First Submit Date:
2022-12-29
First Submit QC Date:
None
Study First Post Date:
2023-01-26
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-01-13
Last Update Post Date:
2023-01-26
Last Update Post Date Type:
ACTUAL